MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features

Pediatric Blood and Cancer

Volumn 62, Issue 1, 2015, Pages 177-178

  de Oliveira, Jaqueline Carvalho ^a   Scrideli, Carlos Alberto ^b   Brassesco, María Sol ^b   Yunes, José Andres ^c,d   Brandalise, Silvia Regina ^c,d   Tone, Luiz Gonzaga ^b  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CENTRO INFANTIL BOLDRINI   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 705 5P; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKOCYTE COUNT; PRIORITY JOURNAL; TREATMENT RESPONSE; UPREGULATION; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84922790983     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25222     Document Type: Letter

References (7)

1. Li X, Li D, Zhuang Y, et al. Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL. Pediatr Blood Cancer 2013; 60:2060-2067.
2. Scrideli CA, Assumpção JG, Ganazza MA, et al. A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica 2009; 94:781-789.
3. Brandalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: Randomized trial from the Brazilian Childhood Cooperative Group-protocol ALL-99. J Clin Oncol 2010; 28:1911-1918.
4. Oliveira JC, Scrideli CA, Brassesco MS, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leuk Res 2012; 36:293-298.
5. Schotte D, Chau JC, Sylvester G, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 2009; 23:313-322.
6. Jiao Y, Cui L, Gao C, et al. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia. Leuk Res 2012; 36:67-71.
7. Luo XQ, Ke ZY, Huang LB, et al. High-risk childhood acute lymphoblastic leukemia in China: Factors influencing the treatment and outcome. Pediatr Blood Cancer 2009; 52:191-195.